Dr. Panagiotis Mallis | Stem Cells | Best Researcher Award
Dr. Panagiotis Mallis | Stem Cells | Manager at Biomedical Research Foundation Academy of Athens | Greece
Dr. Panagiotis Mallis is a highly accomplished researcher at the Hellenic Cord Blood Bank with extensive expertise in mesenchymal stromal cells (MSCs), regenerative medicine, and tissue engineering of small-diameter vascular grafts. He obtained his Ph.D. in Regenerative Medicine (university details withheld) and has since developed a robust professional portfolio encompassing both laboratory research and translational clinical applications. Dr. Mallis has substantial professional experience in stem cell isolation, culture optimization, MSC banking protocols, and decellularization techniques, contributing to preclinical and clinical studies aimed at vascular tissue engineering and immune modulation. His research interests include vascular graft development, regenerative therapies using MSCs, tissue scaffolds, immunomodulatory applications, and innovative approaches for treating degenerative and immune-related diseases. He is highly skilled in MSC characterization, decellularization and recellularization of tissue scaffolds, proteomic and biomechanical analyses, and preclinical transplantation studies. Dr. Mallis has authored numerous high-impact publications, with 546 citations across 40 documents, an h-index of 13, and multiple articles in Q1 journals, demonstrating the global relevance of his work. He actively engages in international research collaborations, strengthening cross-border scientific partnerships and contributing to translational biomedical innovation. His leadership extends to mentoring early-career researchers, coordinating research teams, and participating in professional societies and volunteer initiatives in regenerative medicine and tissue engineering. Dr. Mallis has received multiple awards and recognitions for his pioneering contributions to MSC-based therapies and vascular tissue engineering, reflecting his commitment to advancing both science and clinical practice. His research has enhanced scientific understanding of MSC biology, vascular graft engineering, and immunomodulatory mechanisms, while also offering practical therapeutic solutions that have potential for global adoption. Looking forward, Dr. Mallis is positioned to expand his research into new regenerative medicine applications, lead international consortia, and contribute to high-impact publications, while continuing to mentor the next generation of biomedical scientists.
Academic Profile: ORCID | Scopus | Google Scholar
Featured Publications:
-
Chatzistamatiou, T. K., Papassavas, A. C., Michalopoulos, E., Gamaloutsos, C., Mallis, P., et al. (2014). Optimizing isolation culture and freezing methods to preserve Wharton’s jelly’s mesenchymal stem cell (MSC) properties: An MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion, 54(12), 3108–3120. [Cited by 126]
-
Mallis, P., Kostakis, A., Stavropoulos-Giokas, C., Michalopoulos, E. (2020). Future perspectives in small-diameter vascular graft engineering. Bioengineering, 7(4), 160. [Cited by 119]
-
Protogerou, V., Michalopoulos, E., Mallis, P., Gontika, I., Dimou, Z., Liakouras, C. (2019). Administration of adipose derived mesenchymal stem cells and platelet lysate in erectile dysfunction: A single center pilot study. Bioengineering, 6(1), 21. [Cited by 58]
-
Mallis, P., Gontika, I., Poulogiannopoulos, T., Zoidakis, J., Vlahou, A. (2014). Evaluation of decellularization in umbilical cord artery. Transplantation Proceedings, 46(9), 3232–3239. [Cited by 45]